Dr. Nasir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6550 Fannin Street
Suite 1901
Houston, TX 77030Phone+1 713-441-1100Fax+1 713-790-2643
Education & Training
- London School of Economics and Political SciencesMsc, Health Economics Policy and Management , 2015 - 2017
- Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 2010 - 2013
- Boston University Medical CenterResidency, Internal Medicine, 2009 - 2010
- UPMC Medical EducationResidency, Internal Medicine, 2005 - 2006
- Allama Iqbal Medical CollegeClass of 1999
Certifications & Licensure
- FL State Medical License 2012 - 2026
- TX State Medical License 2019 - 2026
- CT State Medical License 2011 - 2020
- PA State Medical License 2005 - 2006
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- The Miami Heart Study at Baptist Health South Florida Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- Use of e-cigarettes, traditional combustible cigarettes, and high sensitivity C-reactive protein: The Cross Cohort Collaboration.Zhiqi Yao, Erfan Tasdighi, Zeina A Dardari, John Erhabor, Kunal K Jha
American Heart Journal. 2025-02-01 - Cardiovascular disease burden in the North Africa and Middle East region: an analysis of the global burden of disease study 1990-2021.Hamidreza Soleimani, Ali Nasrollahizadeh, Amir Nasrollahizadeh, Iman Razeghian, Mohammad Mahdi Molaei
BMC Cardiovascular Disorders. 2024-12-19 - Trends in Cardiovascular Disease-Related Mortality in Texas.Muhammad Shariq Usman, Adeena Jamil, Zainali Chunawala, Mahboob Alam, Vijay Nambi
Texas Heart Institute Journal. 2024-12-19
Journal Articles
- Sociodemographic Disparities in Influenza Vaccination Among Adults with Atherosclerotic Cardiovascular Disease in the United StatesRon Blankstein, Michael J Blaha, Salim S Virani, Khurram Nasir, JAMA Cardiology
- Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsSeamus P Whelton, John W Mcevoy, Matthew Budoff, Khurram Nasir, Roger S Blumenthal, Michael J Blaha, JAMA Cardiology
- Association of Out-of-Pocket Annual Health Expenditures with Financial Hardship in Low-Income Adults with Atherosclerotic Cardiovascular Disease in the United StatesHarlan M Krumholz, Khurram Nasir, Sandeep R Das, Rohan Khera, JAMA
- Join now to see all
Authored Content
- Influenza Vaccination for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: Efficacy/Effectiveness of Vaccination and Disparities in Vaccine Coverage in the USOctober 2020
- Digital Phenotyping of Myocardial Dysfunction with 12-Lead ECG Tiptoeing into the Future with Machine LearningAugust 2020
- Digital Phenotyping of Myocardial Dysfunction with 12-Lead ECG Tiptoeing into the Future with Machine LearningAugust 2020
- Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
- Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
- Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
- Original Research Coronary Artery Calcium and Cardiovascular Events in Patients with Familial Hypercholesterolemia Receiving Standard Lipid-Lowering TherapyNovember 2018
- Original Research Coronary Artery Calcium and Cardiovascular Events in Patients with Familial Hypercholesterolemia Receiving Standard Lipid-Lowering TherapyNovember 2018
- Original Research Coronary Artery Calcium and Cardiovascular Events in Patients with Familial Hypercholesterolemia Receiving Standard Lipid-Lowering TherapyNovember 2018
- Impact of C-reactive Protein and Coronary Artery Calcium on Benefit Observed with AtorvastatinMay 2018
- Reply Cardiovascular Risk Models and Statin TherapyMay 2018
- The Prognostic Value of High Sensitivity C-reactive Protein in a Multi-Ethnic Population After >10 Years of Follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA)May 2018
- 10-Year Resource Utilization and Costs for Cardiovascular CareMarch 2018
- Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI RegistryJanuary 2018
- Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI RegistryJanuary 2018
- Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI RegistryJanuary 2018
- Join now to see all
Press Mentions
- Houston Methodist Scientists Make Surprising Discovery Pinpointing When Good Cholesterol Becomes HarmfulDecember 19th, 2024
- Houston Methodist, Rice Partner to Use AI, Other Technologies to Transform Health CareDecember 17th, 2024
- HeartLung Technologies Receives FDA "Breakthrough" Status and Marketing Authorization for the First Opportunistic AI to Help Detect Heart Disease in Millions of CT ScansOctober 29th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: